Assertio Therapeutics Stock Market Value
| ASRT Stock | USD 11.73 0.08 0.68% |
| Symbol | Assertio |
Is there potential for Stock market expansion? Will Assertio introduce new products? Factors like these will boost the valuation of Assertio Therapeutics. If investors know Assertio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Assertio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Assertio Therapeutics requires distinguishing between market price and book value, where the latter reflects Assertio's accounting equity. The concept of intrinsic value—what Assertio Therapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Assertio Therapeutics' price substantially above or below its fundamental value.
Understanding that Assertio Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assertio Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Assertio Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Assertio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Assertio Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Assertio Therapeutics.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Assertio Therapeutics on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Assertio Therapeutics or generate 0.0% return on investment in Assertio Therapeutics over 90 days. Assertio Therapeutics is related to or competes with INC Research, Nutriband, XBiotech, Fortress Biotech, Acrivon Therapeutics, Tscan Therapeutics, and Pulmonx Corp. Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and... More
Assertio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Assertio Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Assertio Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.39 | |||
| Information Ratio | 0.0236 | |||
| Maximum Drawdown | 24.64 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.07 |
Assertio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assertio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Assertio Therapeutics' standard deviation. In reality, there are many statistical measures that can use Assertio Therapeutics historical prices to predict the future Assertio Therapeutics' volatility.| Risk Adjusted Performance | 0.0366 | |||
| Jensen Alpha | 0.0846 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0272 | |||
| Treynor Ratio | 0.125 |
Assertio Therapeutics January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0366 | |||
| Market Risk Adjusted Performance | 0.135 | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 3.15 | |||
| Downside Deviation | 3.39 | |||
| Coefficient Of Variation | 2546.97 | |||
| Standard Deviation | 3.91 | |||
| Variance | 15.3 | |||
| Information Ratio | 0.0236 | |||
| Jensen Alpha | 0.0846 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0272 | |||
| Treynor Ratio | 0.125 | |||
| Maximum Drawdown | 24.64 | |||
| Value At Risk | (4.63) | |||
| Potential Upside | 6.07 | |||
| Downside Variance | 11.49 | |||
| Semi Variance | 9.89 | |||
| Expected Short fall | (2.97) | |||
| Skewness | 1.1 | |||
| Kurtosis | 3.46 |
Assertio Therapeutics Backtested Returns
Currently, Assertio Therapeutics is somewhat reliable. Assertio Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0393, which signifies that the company had a 0.0393 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Assertio Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Assertio Therapeutics' Risk Adjusted Performance of 0.0366, mean deviation of 2.68, and Downside Deviation of 3.39 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%. Assertio Therapeutics has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.15, which signifies a somewhat significant risk relative to the market. Assertio Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Assertio Therapeutics is expected to follow. Assertio Therapeutics right now shows a risk of 3.91%. Please confirm Assertio Therapeutics value at risk, as well as the relationship between the kurtosis and price action indicator , to decide if Assertio Therapeutics will be following its price patterns.
Auto-correlation | 0.09 |
Virtually no predictability
Assertio Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Assertio Therapeutics time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Assertio Therapeutics price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Assertio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 1.01 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.